|
|
Posted by Elaine Moore Mar 30, 2006 |
ITP frequently occurs after viral infection and in people with other autoimmune disorders. ITP is also known to occur after the use of certain medications including heparin used in the treatment of clotting disorders.
In ITP the immune system produces antibodies that destroy platelets. Several different platelet antibodies known to injure the platelet cell membrane are associated with ITP. Blood tests for platelet antibodies are used to diagnose ITP in people with low platelet counts. The bone marrow functions normally in ITP, that is, platelets are produced normally. They are destroyed by platelet antibodies in the blood circulation. Patients with ITP may also have lupus anticoagulant, particularly anticardiolipin or antiphospholipid antibodies.
The normal or reference range for platelets is 150,000-350,000. In moderate to severe ITP, when platelet counts fall below 20,000, patients are at risk for hemorrhage, a type of uncontrolled bleeding. The mortality rate from hemorrhage in ITP is 1 percent in children and 5 percent in adults. Higher mortality is seen in patients older than 60 years compared to patients less than 40 years old. In children, ITP is generally an acute condition, resolving within a few months in 80 percent of children. In children, males and females are equally affected. In adults, about 72 percent of patients are female.
Besides heparin, the medications quinine, quinidine, sulfa compounds, and alcohol can contribute to ITP. In children, ITP may develop after the administration of live vaccines.
Symptoms of ITP include increased bruising, heavy menstrual periods, retinal hemorrhages, gastrointestinal bleeding, normal coagulation tests (Protime and PTT), and gingival (gum) bleeding.
Treatment consists of corticosteroids, intravenous immunoglobulins, platelet transfusions, with best results if platelets are transfused after intravenous immunoglobulin therapy, and as a last resort spleen removal (splenectomy) in patients who do not respond to medical treatment.